col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


181 Results       Page 1

 [1] 
Future Medicine: Future Virology
  original article Date Title Authors   All Authors
1 [GO] 2024―Jun―17 Genomic epidemiology and phylogeographic dynamics of SARS-CoV-2 during the sixth wave and post-sixth wave in Pakistan Zunera Jamal, Syed Adnan Haider, Muhammad Ammar, Zaira Rehman, Afreenish Amir, Aamer Ikram, et al. (+2)
2 [GO] 2024―Jun―17 Remarkable proliferative ability of the Omicron variant in the nasal cavity compared to other SARS-CoV-2 variants Hirokazu Yamagishi, Daisuke Tamura, Yuji Morisawa, Takashi Mato, Shin Nunomiya, Toshihiro Tajima, Hitoshi Osaka
3 [GO] 2024―Jun―05 Resistance analysis in the phase III COMET-TAIL study: treatment of COVID-19 with intramuscular or intravenous sotrovimab Maria L Agostini, Gretja Schnell, Julia di Iulio, Anita Kohli, Adrienne E Shapiro, Elias H Sarkis, et al. (+7)
4 [GO] 2024―May―18 Coping with the Third wave of the COVID-19 Pandemic in Africa: Implications for an Improved Outbreak Response Olayinka Stephen Ilesanmi, Francesco Chirico, Aanuoluwapo Adeyimika Afolabi, Gabriella Nucera
5 [GO] 2024―Apr―12 RNAi-mediated inhibition of SARS-CoV-2: applications and challenges Debosmita Sanyal, Binay Chaubey
6 [GO] 2024―Mar―26 Exploration of the cross-immunity between SARS-CoV and SARS-CoV-2 in mice Shuhui Wang, Li Ren, Ying Liu, Xiuli Shen, Yanling Hao, Yiming Shao
7 [GO] 2024―Mar―18 Direct virus capture assay for label-free detection of SARS-CoV-2 virions using laser microscopy Alessandro Pennesi, Guglielmo Ferrari, Federica Giardina, Sara Piselli, Roberto Lo Savio, Adolfo Carloni, et al. (+2)
8 [GO] 2024―Feb―26 Real-life use of high-dose anakinra in patients with COVID-19 treated with remdesivir Roberta Monardo, Andrea Mastrangelo, Laura Galli, Alessandro Tomelleri, Vincenzo Spagnuolo, Chiara Oltolini, et al. (+9)
9 [GO] 2024―Feb―09 Developing a risk prediction model for COVID-19 infection in heart transplant recipients using artificial intelligence Shriya Sharma, Nora Menon, Jose Ruiz, Caitlyn Luce, Lisa Brumble, Anirban Bhattacharya, Rohan Goswami
10 [GO] 2024―Feb―05 Preliminary application of a coronavirus pseudovirus system Xiaoli Tao, Tengfei Li, Baojun He, Wei Zhao, Siman Hu, Zhuping Ma, et al. (+4)
11 [GO] 2023―Dec―21 Resistance analysis following sotrovimab treatment in participants with COVID-19 during the phase III COMET-ICE study Sambhavi Subramanian, Gretja Schnell, Julia di Iulio, Anil K Gupta, Adrienne E Shapiro, Elias H Sarkis, et al. (+5)
12 [GO] 2023―Dec―19 Effect of the COVID-19 pandemic on the reporting of Crimean-Congo hemorrhagic fever Mohammad Hassan Pouriayevali, Ehsan Mostafavi, Mehdi Fazlalipour, Tahmineh Jalali, Sahar Khakifirouz, Seyed Dawood Mosavi-Nasab, Mostafa Salehi-Vaziri
13 [GO] 2023―Nov―07 Validation of a risk prediction model for COVID-19: the PERIL prospective cohort study Shahd A Mohammedain, Saif Badran, AbdelNaser Y Elzouki, Halla Salim, Ayesha Chalaby, MYA Siddiqui, et al. (+7)
14 [GO] 2023―Nov―07 Antiviral attributes of bee venom as a possible therapeutic approach against SARS-CoV-2 infection Soumik Goswami, Jayita Pal Chowdhury
15 [GO] 2023―Nov―01 Oral bemnifosbuvir (AT-527) vs placebo in patients with mild-to-moderate COVID-19 in an outpatient setting (MORNINGSKY) Arantxa Horga, Rebecca Saenz, Gürdal Yilmaz, Abraham Simón-Campos, Keith Pietropaolo, William J Stubbings, et al. (+10)
16 [GO] 2023―Oct―26 In silico identification of deep-sea fungal alkaloids as potential inhibitors of SARS-CoV-2, Delta and Omicron spikes Abdullah R Alanzi, Mohammad K Parvez, Mohammed S Al-Dosari
17 [GO] 2023―Oct―18 Genotoxicity: a neglected but potentially critical aspect of adenoviral COVID-19 vaccines Alireza Mardomi, Tahoora Mousavi, Farahnoosh Farnood, Hamid Tayebi Khosroshahi
18 [GO] 2023―Sep―19 ‘The end’ - or is it? Emergence of SARS-CoV-2 EG.5 and BA.2.86 subvariants Farid Rahimi, Mohammad Darvishi, Amin Talebi Bezmin Abadi
19 [GO] 2023―Sep―11 Targeting host calcium channels and viroporins: a promising strategy for SARS-CoV-2 therapy Mona Fani, Maryam Moossavi, Hasan Bakhshi, Abozar Nasiri Jahrodi, Mohammad Reza Khazdair, Amir Hossein Zardast, Shokouh Ghafari
20 [GO] 2023―Jul―28 Plain Language Summary of a Clinical Trial Evaluating mRNA-1273, Moderna's mRNA-Based COVID-19 Vaccine, in Children 6 Through 11 Years of Age CB Creech, E Anderson, V Berthaud, I Yildirim, AM Atz, I Melendez Baez, et al. (+22)
21 [GO] 2023―Jul―13 Expression of TRIM56 gene in SARS-CoV-2 variants and its relationship with progression of COVID-19 Rezvan Tavakoli, Pooneh Rahimi, Mojtaba Hamidi-Fard, Sana Eybpoosh, Delaram Doroud, Iraj Ahmadi, et al. (+3)
22 [GO] 2023―Jun―24 Design and generation of mRNAs encoding conserved regions of SARS-CoV-2 ORF1ab for T cell-mediated immune activation Cao Minh Nguyen, Bac An Luong, Thu Thuy Thi Tran, Hoai Nghia Nguyen, Le Son Tran
23 [GO] 2023―Jun―23 Phase II study of bemnifosbuvir in high-risk participants in a hospital setting with moderate COVID-19 Arantxa Horga, Daniel R. Kuritzkes, John J. Kowalczyk, Keith Pietropaolo, Bruce Belanger, Kai Lin, et al. (+2)
24 [GO] 2023―Jun―16 COVID-19 post vaccination neuronal adverse events: probable mechanisms and treatment possibilities Abdul Mannan Baig, Joachim Gerlach, Prakash Salunke, Rachel Jessey, Robin Rose
25 [GO] 2023―Jun―16 Effects of COVID-19 and vaccination on the human immune system: cases of lymphopenia and autoimmunity Joachim Gerlach, Abdul Mannan Baig
26 [GO] 2023―Jun―07 Plant protease inhibitors against SARS-CoV-2 main protease: an in silico approach Adrianne M Lima, Adson A de Souza, Jackson L Amaral, Valder N Freire, Pedro F N Souza, Hermógenes D de Oliveira
27 [GO] 2023―Jun―01 CpG 684: an effective adjuvant for the inactivated COVID-19 vaccine in mice Jiandong Liu, Tianle Cang, Congli Jiang, Kelei Li, Siyuan Liu, Haixin Wang, et al. (+4)
28 [GO] 2023―Jun―01 Structure-based virtual identification of natural inhibitors of SARS-CoV-2 and its Delta and Omicron variant proteins Abdullah R Alanzi, Mohammad K Parvez, Mohammed S Al-Dosari
29 [GO] 2023―May―22 In silico assessment of diterpenes as potential inhibitors of SARS-COV-2 main protease Yousef A Abdelrady, Naeem Mahmood Ashraf, Arslan Hamid, Hayam S Thabet, Asmaa M Sayed, Shimaa H Salem, et al. (+2)
30 [GO] 2023―May―22 Identification of host factors that bind to the 5′ end of the MERS-CoV RNA genome Bader Y Alhatlani, Waleed Aljabr, Fatimah S Alhamlan, Ahmad Almatroudi, Mohd Azam, Mansour Alsaleem, Khaled S Allemailem
31 [GO] 2023―Apr―17 Efficiency rating of SG Diagnostics COVID-19 antigen rapid test kit Francesco Chirico, Murat Yıldırım, Tomasz Dzieciatkowski, Marek Dabrowski, Marek Malysz, Marcin Madziala, et al. (+5)
32 [GO] 2023―Apr―11 DPP-4 Inhibitors as a savior for COVID-19 patients with diabetes Snehasish Nag, Samanwita Mandal, Oindrila Mukherjee, Suprabhat Mukherjee, Rakesh Kundu
33 [GO] 2023―Apr―11 In silico analysis of ACE2 from different animal species provides new insights into SARS-CoV-2 species spillover Felipe Pantoja Mesquita, Pedro Filho Noronha Souza, Dyane Rocha Aragão, Expedito Maia Diógenes, Emerson Lucena da Silva, Jackson Lima Amaral, et al. (+3)
34 [GO] 2023―Apr―06 The impact of mutation sets in receptor-binding domain of SARS-CoV-2 variants on the stability of RBD-ACE2 complex Mykyta Peka, Viktor Balatsky
35 [GO] 2023―Apr―04 Evidence-based policies in public health to address COVID-19 vaccine hesitancy Francesco Chirico, Jaime A Teixeira da Silva
36 [GO] 2023―Mar―14 Natural killer cells in COVID-19: from infection, to vaccination and therapy Alireza Zafarani, Mohammad Hossein Razizadeh, Salar Pashangzadeh, Mohammad Reza Amirzargar, Mahsa Taghavi-Farahabadi, Mohammad Mahmoudi
37 [GO] 2023―Mar―09 A twisting tale of misinformation: should ivermectin be approved as a treatment for COVID-19 disease? Arman Shafiee, Mohammad Mobin Teymouri Athar, Sayed-Hamidreza Mozhgani
38 [GO] 2023―Mar―06 Two sides of the same coin: the N-terminal and the receptor binding domains of SARS-CoV-2 Spike Massimo Ciccozzi, Stefano Pascarella
39 [GO] 2023―Feb―20 HLA and red blood cell antigen genotyping in SARS-CoV-2 convalescent plasma donors William Lemieux, Josée Perreault, Gabriel André Leiva-Torres, Nadia Baillargeon, Jessica Constanzo Yanez, Marie-Claire Chevrier, et al. (+3)
40 [GO] 2023―Feb―03 SARS-CoV-2 RNA-dependent RNA polymerase as a target for high-throughput drug screening Jiahui Wu, Zhiqiang Chen, Xue Han, Qiaoqiao Chen, Yintao Wang, Tingting Feng
41 [GO] 2023―Jan―27 Is the emergence of the zoonotic Langya virus amidst COVID-19 and monkeypox a cause for concern? Chandan Kumar Thakur, Jog Bahadur Adhikari, Nitin Gupta, Prakash Ghimire, Meghnath Dhimal
42 [GO] 2023―Jan―19 Update on the treatment of multisystem inflammatory syndrome in children associated with COVID-19 Fangyuan Long, Shiheng Zhu, Zeguang Wang, Shungeng Zhang, Jinlong He, Xinbin Ge, Jun Ning
43 [GO] 2023―Jan―16 Plain language summary of Pfizer-BioNTech BNT162b2 vaccine protection against COVID-19 and its safety in participants 12- to 15-years-old Robert W Frenck, Nicola P Klein, Nicholas Kitchin, Alejandra Gurtman, Judith Absalon, Stephen Lockhart, et al. (+20)
44 [GO] 2023―Jan―10 Diagnosing COVID-19: diagnostic importance of detecting E gene of the SARS-CoV-2 genome Iva Barjaktarović, Jelena Stojčević Maletić, Nataša Vučinić, Aleksandra Milutinović, Maja Grujičić, Velibor Čabarkapa
45 [GO] 2023―Jan―09 The prevalence of deep vein thrombosis and associated risk factors among patients with COVID-19 in the North of Iran Maryam Yaseri, Seyyedeh Sahereh Mortazavi Khatibani, Elahe Ghorbani Totkaboni, Haniyeh Sadat Fayazi
46 [GO] 2022―Nov―25 Plain language summary of Pfizer-BioNTech BNT162b2 COVID-19 vaccine safety in participants 16 years or older and protection against COVID-19 in participants 12 years or older Stephen J Thomas, Edson D Moreira, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, et al. (+26)
47 [GO] 2022―Oct―22 Variation analysis of SARS-CoV-2 complete sequences from Iran Jale Moradi, Parnia Moradi, Amir H Alvandi, Ramin Abiri, Mohsen Moghoofei
48 [GO] 2022―Oct―17 Blood types (ABO/Rhesus) and SARS-CoV-2 infection: a retrospective, cross-sectional study in 2828 healthcare workers Betul Copur, Serkan Surme, Ugurcan Sayili, Gulsah Tuncer, Melike Nur Ozcelik, Hulya Yilmaz-Ak, et al. (+4)
49 [GO] 2022―Sep―26 Reinfection and reactivation of SARS-CoV-2 Razieh Dowran, Amirmasoud Rayati Damavandi, Talat Mokhtari Azad
50 [GO] 2022―Sep―26 Rapid antigen test for SARS-CoV-2: results of validation and use in real life Irena Grmek Kosnik, Urska Dermota, Andrej Golle, Tjasa Zohar Cretnik
51 [GO] 2022―Sep―23 Similarity between cutaneous reactions due to SARS-CoV-2 and its vaccinations Ömer Kutlu, Selami Aykut Temiz
52 [GO] 2022―Sep―16 Relevance of cycle threshold values in mass screening by reverse-transcription-PCR during COVID-19 pandemic in Belgium: a decision-making support? Patrice Dufour, Henry Paridaens, Jean-Marc Senterre, Jean-Marc Minon
53 [GO] 2022―Sep―14 A plain language summary of the Janssen COVID-19 vaccine effectiveness and safety as a single dose and with a booster Frank Struyf, Jerald Sadoff, Karin Hardt, Macaya Douoguih
54 [GO] 2022―Aug―31 Sudden onset of decreased vision following Delta variant of SARS-CoV-2 infection: a case report Akram Sadat Ahmadi, Nazanin Zahra Shafiei-Jandaghi, Kaveh Sadeghi, Mohammadreza Salehi, Talat Mokhtari-Azad, Jila Yavarian
55 [GO] 2022―Aug―08 Digging for the discovery of SARS-CoV-2 nsp12 inhibitors: a pharmacophore-based and molecular dynamics simulation study Fatemeh Sana Askari, Mohsen Ebrahimi, Jabbar Parhiz, Mina Hassanpour, Alireza Mohebbi, Abbas Mirshafiey
56 [GO] 2022―Aug―02 Cholesterol-lowering drugs for high-risk hypercholesterolemia patients with COVID-19 while on Paxlovid™ therapy Alpo Vuorio, Petri T Kovanen, Frederick Raal
57 [GO] 2022―Aug―02 Structural analysis of spike proteins from SARS-CoV-2 variants of concern highlighting their functional alterations Kundan Solanki, Sajjan Rajpoot, Ashutosh Kumar, Kam Y J Zhang, Tomokazu Ohishi, Nik Hirani, et al. (+4)
58 [GO] 2022―Jul―22 Tripartite communication in COVID-19 infection: SARS-CoV-2 pathogenesis, gut microbiota and ACE2 Sara Ahmadi Badi, Shohreh Khatami, Seyed Davar Siadat
59 [GO] 2022―Jul―19 A rare case of septic pulmonary embolism in co-existence with infective endocarditis and COVID-19 Yusuf Emre Ozdemir, Adile Sevde Demir, Meryem Sahin Ozdemir, Busra Mavi, Can Ozen, Hayat Kumbasar Karaosmanoglu
60 [GO] 2022―Jul―19 Nothing in SARS-CoV-2 makes sense except in the light of RNA modification? Mingmei Zhao, Chunxiao Li, Yu Dong, Xuekun Wang, Wenqing Jiang, Yaogang Chen
61 [GO] 2022―Jul―01 Molecular and antigen tests, and sample types for diagnosis of COVID-19: a review Yujia Zhang, Rachael Garner, Sana Salehi, Marianna La Rocca, Dominique Duncan
62 [GO] 2022―Jul―01 SARS-CoV-2 and its repercussive effect on reproductive health: recent trends Sukanth Kumar Enmozhi, Jerrine Joseph
63 [GO] 2022―Jun―28 IGA nephropathy and spinal epidural abscess after COVID-19 infection: a case report Burak Göre, Ezgi Coşkun Yenigün, Şimal Köksal Cevher, Emre Çankaya, Numan Aydın, Fatih Dede
64 [GO] 2022―Jun―16 A comprehensive account of SARS-CoV-2 genome structure, incurred mutations, lineages and COVID-19 vaccination program Vijay Rani Rajpal, Shashi Sharma, Deepmala Sehgal, Apekshita Singh, Avinash Kumar, Samantha Vaishnavi, et al. (+4)
65 [GO] 2022―Jun―15 Clinical course of idiopathic inflammatory myopathies in COVID-19 pandemic: a single-center experience Hakan Apaydin, Abdulsamet Erden, Serdar C Güven, Berkan Armağan, Özlem Karakaş, Bahar Özdemir, et al. (+4)
66 [GO] 2022―Jun―08 Detection of SARS-CoV-2 N501Y mutation among SARS-CoV-2 variants of concern circulating in Northern Cyprus Gulten Tuncel, Mahmut Cerkez Ergoren, Buket Baddal, Pinar Tulay, Cenk Serhan Ozverel, Emrah Guler, et al. (+3)
67 [GO] 2022―Jun―03 Mapping of SARS-CoV-2 spike protein evolution during first and second waves of COVID-19 infections in India Vijay Rani Rajpal, Shashi Sharma, Avinash Kumar, Samantha Vaishnavi, Apekshita Singh, Deepmala Sehgal, et al. (+3)
68 [GO] 2022―Jun―03 Efficacy and safety of corticosteroid regimens for the treatment of hospitalized COVID-19 patients: a meta-analysis Fangwen Zhou, Jiawen Deng, Kiyan Heybati, Qi Kang Zuo, Saif Ali, Wenteng Hou, et al. (+5)
69 [GO] 2022―May―09 Evaluation of SARS-CoV-2 genome detection by real-time PCR assay using pooled specimens Forough Tavakoli, Jila Yavarian, Nazanin Zahra Shafiei Jandaghi, Kaveh Sadeghi, Nastaran Ghavami, Vahid Salimi, Talat Mokhtari-Azad
70 [GO] 2022―Apr―26 Neutralization heterogeneity of circulating SARS-CoV-2 variants to sera elicited by a vaccinee or convalescent Meng Zhang, Yixin Gong, Shunchang Jiao
71 [GO] 2022―Apr―19 Need for more robust research on the effectiveness of masks in preventing COVID-19 transmission Jingjing Nie, Linna Kang, Yaya Pian, Jihong Hu
72 [GO] 2022―Apr―19 Toll-like receptor 4 in COVID-19: friend or foe? Suprabhat Mukherjee
73 [GO] 2022―Apr―11 Evaluation of rapid antigen detection kits for detection of SARS-CoV-2 B.1.617.2 virus Gannon CK Mak, Stephen SY Lau, Kitty KY Wong, Nancy LS Chow, Chi-Shan Lau, Edman TK Lam, et al. (+2)
74 [GO] 2022―Apr―05 Reviewing findings on the polypeptide sequence of the SARS-CoV-2 S-protein to discuss the origins of the virus Alberto Maria Cattaneo
75 [GO] 2022―Apr―04 In silico discovery of non-psychoactive scaffolds in Cannabis halting SARS-CoV-2 host entry and replication machinery Amira R Khattab, Mohamed Teleb
76 [GO] 2022―Mar―21 Can anti-parasitic drugs help control COVID-19? Yasin Panahi, Masoomeh Dadkhah, Sahand Talei, Zahra Gharari, Vahid Asghariazar, Arash Abdolmaleki, et al. (+2)
77 [GO] 2022―Mar―17 A community call to action: mitigating COVID pandemic’s impact on mental health Wahid Ullah, Muhammad Ilyas, Mukhtar Alam, Jong Bhak, Peter J Tonellato
78 [GO] 2022―Mar―08 Massive third wave of COVID-19 outbreak in Bangladesh: a co-epidemic of dengue might worsen the situation Popy Devnath, Md. Jamal Hossain, Talha Bin Emran, Saikat Mitra
79 [GO] 2022―Mar―01 Airborne transmission of SARS-CoV-2 disease (COVID-19) Mohammad K Parvez, Shama Parveen
80 [GO] 2022―Feb―21 A nomogram predicting the severity of COVID-19 based on initial clinical and radiologic characteristics Hanfei Zhang, Feiyang Zhong, Binchen Wang, Meiyan Liao
81 [GO] 2022―Feb―11 Cervical and preauricular lymphadenopathies as atypical manifestations in the setting of COVID-19: a case report Alireza Ala, Solomon Habtemariam, Samad Shams Vahdati, Aysa Rezabakhsh
82 [GO] 2022―Feb―10 Research progresses in vertical transmission of SARS-CoV-2 among infants born to mothers with COVID-19 Zhoujie Peng, Jing Zhang, Yuan Shi, Ming Yi
83 [GO] 2022―Feb―10 Antineutrophil cytoplasmic antibody positivity and clinical implications in COVID-19 Serdar Can Güven, Hakan Apaydın, Bahar Özdemir, Berkan Armağan, İhsan Ateş, Abdulsamet Erden, et al. (+2)
84 [GO] 2022―Feb―10 Computed tomography evaluation of pancreatic steatosis: correlation with COVID-19 prognosis Serkan Guneyli, Hakan Dogan, Omer Tarik Esengur, Hur Hassoy
85 [GO] 2022―Jan―31 Efficacy of lopinavir-ritonavir combination therapy for the treatment of hospitalized COVID-19 patients: a meta-analysis Jiawen Deng, Fangwen Zhou, Wenteng Hou, Kiyan Heybati, Saif Ali, Oswin Chang, et al. (+7)
86 [GO] 2022―Jan―12 Rethinking methods used to evaluate effectiveness of therapeutics for COVID-19 and other viral respiratory illnesses Jean-François Rossignol
87 [GO] 2022―Jan―12 Anterior ischemic optic neuropathy as a rare manifestation of COVID-19: a case report Khodayar Golabchi, Alireza Rezaee, Davood Aghadoost, Maryam Hashemipour
88 [GO] 2021―Dec―15 A systematic review and meta-analysis of the sensitivity of antibody tests for the laboratory confirmation of COVID-19 Nigel A Makoah, Thomas Tipih, Matefo M Litabe, Mareza Brink, Joseph B Sempa, Dominique Goedhals, Felicity J Burt
89 [GO] 2021―Dec―15 Identifying asymptomatic cases during the mass COVID-19 vaccination campaign: insights and implications for policy makers Francesco Chirico, Gabriella Nucera, Olayinka Ilesanmi, Aanuoluwapo Afolabi, Michal Pruc, Lukasz Szarpak
90 [GO] 2021―Dec―15 Performance of six SARS-CoV-2 RNA detection systems in symptomatic and asymptomatic pediatric and maternal patients Cameron A Brown, Megan H Amerson-Brown, Aliza Rahman, Charity R Webb, Ila R Singh, James J Dunn
91 [GO] 2021―Dec―06 Myocarditis and COVID-19 mRNA vaccines: a mechanistic hypothesis involving dsRNA Gerard Milano, Jocelyn Gal, Anne Creisson, Emmanuel Chamorey
92 [GO] 2021―Dec―03 Efficacy of chloroquine and hydroxychloroquine for the treatment of hospitalized COVID-19 patients: a meta-analysis Jiawen Deng, Fangwen Zhou, Kiyan Heybati, Saif Ali, Qi Kang Zuo, Wenteng Hou, et al. (+5)
93 [GO] 2021―Nov―26 A brief review on DNA vaccines in the era of COVID-19 Maryam Shafaati, Massoud Saidijam, Meysam Soleimani, Fereshte Hazrati, Rasoul Mirzaei, Bagher Amirheidari, et al. (+9)
94 [GO] 2021―Nov―26 Non-SARS, non-MERS human coronavirus infections and risk of Kawasaki disease: a meta-analysis Pratap Kumar Patra, Rashmi Ranjan Das, Aaqib Zaffar Banday, Mini Singh, Kapil Goyal, Ankur Kumar Jindal, Surjit Singh
95 [GO] 2021―Nov―26 Pediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 symptoms in Iran Mehran Akbari, Mojtaba Didehdar, Mohsen Nazari, Davood Azadi
96 [GO] 2021―Nov―12 Detection and predictors of anti-SARS-CoV-2 antibody levels in COVID-19 patients at 8 months after symptom onset Jing Guo, Li Li, Qian Wu, Hongwei Li, Yajie Li, Xinwei Hou, et al. (+2)
97 [GO] 2021―Nov―12 Temporal variations of country-specific mutational profile of SARS-CoV-2: effect on vaccine efficacy Sayantan Laha, Raghunath Chatterjee
98 [GO] 2021―Nov―04 The Mu strain: the last but not least circulating ‘variant of interest’ potentially affecting the COVID-19 pandemic Farid Rahimi, Negin Kamali, Amin Talebi Bezmin Abadi
99 [GO] 2021―Nov―04 In-hospital clinical complications of COVID-19: a brief overview Kevin John John, Jemimah Nayar, Ajay Kumar Mishra, Vijairam Selvaraj, Mohammad Saud Khan, Amos Lal
100 [GO] 2021―Nov―04 The third booster vaccination dose against COVID-19: indication for circulating SARS-CoV-2 variants Farid Rahimi, Amin Talebi Bezmin Abadi
101 [GO] 2021―Nov―04 SARS-CoV-2 nomenclature: viruses, variants and vaccines need a standardized naming system Tariq Khan, Syed Muhammad Jamal
102 [GO] 2021―Oct―29 The international treaty for pandemic preparedness and response: same story, different times? Dominique Vervoort, Xiya Ma, Alia Sunderji, Hloni Bookholane
103 [GO] 2021―Oct―19 Rare cutaneous manifestation of COVID-19 infection and Pfizer-BioNTech COVID-19 vaccine with a unique pattern similarity Anthony Fata, Georges Jabbour, Hampig Kourie, Marianne Zoghbi, Elia Kassouf, Antoine Zoghbi
104 [GO] 2021―Oct―14 Detection of SARS-CoV-2 in the sewerage system in Tunisia: a promising tool to confront COVID-19 pandemic Habib Jmii, Hakima Gharbi-Khelifi, Raouia Assaoudi, Mahjoub Aouni
105 [GO] 2021―Oct―08 Computed tomography-positive, SARS-CoV-2 RNA-negative symptomatic contacts of COVID-19 patients: what are their nature and implications? Lei Huang
106 [GO] 2021―Oct―08 A case series of pediatric COVID-19 with complicated symptoms in Iran Fatemeh Cheraghali, Leila Barati, Dayan Amanian, Lobat Shahkar, Maryam Najafinejad, Hamed Naziri, et al. (+3)
107 [GO] 2021―Sep―22 Association between blood groups and COVID-19 outcome in Iranian patients Ali Asghar Ayatollahi, Bahman Aghcheli, Abolfazl Amini, Hasan Nikbakht, Parastoo Ghassemzadehpirsala, Emad Behboudi, et al. (+2)
108 [GO] 2021―Sep―21 High-value laboratory testing for hospitalized COVID-19 patients: a review Daniela Cihakova, Michael B Streiff, Steven P Menez, Teresa K Chen, Nisha A Gilotra, Erin D Michos, et al. (+8)
109 [GO] 2021―Sep―10 Fast evolution of SARS-CoV-2 driven by deamination systems in hosts Yanping Zhang, Wen Jiang, Yan Li, Xiaojie Jin, Xiaoping Yang, Pirun Zhang, et al. (+2)
110 [GO] 2021―Sep―02 Serum biochemical parameters as a surrogate marker for chest computed tomography in children with COVID-19 Karuna M Das, Rajvir Singh, Sandeep Subramanya, Shreesh Kumar Ojha, Taleb Almansoori, Dilip Gokhale, Jamal Aldeen Alkoteesh
111 [GO] 2021―Sep―02 mRNA-based COVID-19 vaccines appear not to increase immune events in cancer patients receiving immune checkpoint inhibitors Emre Yekedüz, Rüveyda Ayasun, Elif Berna Köksoy, Güngör Utkan, Yüksel Ürün, Hakan Akbulut
112 [GO] 2021―Aug―09 Harnessing immunological targets for COVID-19 immunotherapy Abhishesh Kumar Mehata, Matte Kasi Viswanadh, Vishnu Priya, Madaswamy S Muthu
113 [GO] 2021―Jul―29 Independent and incremental prognostic value of D-dimer in hospitalized COVID-19 patients Gerald Chi, Sahar Memar Montazerin, Jane J Lee
114 [GO] 2021―Jul―20 Potential drugs against COVID-19 revealed by gene expression profile, molecular docking and molecular dynamic simulation Claudia Cava, Gloria Bertoli, Isabella Castiglioni
115 [GO] 2021―Jul―20 An overview of sex hormones in relation to SARS-CoV-2 infection Marzieh Saei Ghare Naz, Mojdeh Banaei, Sareh Dashti, Fahimeh Ramezani Tehrani
116 [GO] 2021―Jul―20 In silico discovery of SARS-CoV-2 main protease inhibitors from the carboline and quinoline database Eldar Muhtar, Mengyang Wang, Haimei Zhu
117 [GO] 2021―Jul―13 Reappraisal of trifluperidol against Nsp3 as a potential therapeutic for novel COVID-19: a molecular docking and dynamics study Ajita Pandey, Mohit Sharma
118 [GO] 2021―Jul―13 Targeting SARS-CoV-2 nonstructural protein 15 endoribonuclease: an in silico perspective Shafi Mahmud, Abdo A Elfiky, Al Amin, Sumon Chandro Mohanto, Ekhtiar Rahman, Uzzal Kumar Acharjee, Abu Saleh
119 [GO] 2021―Jul―08 Association of anemia and COVID-19 in hospitalized patients Chong Chen, Wenhui Zhou, Wenliang Fan, Xianying Ning, Shuai Yang, Ziqiao Lei, Chuansheng Zheng
120 [GO] 2021―Jul―06 Association of administration of IFN-α with mortality among patients hospitalized with coronavirus disease 2019 Hanqing Liu, Zhouru Ruan, Ziwei Yin, Dan Wu, Hong Zhu
121 [GO] 2021―Jun―30 Safety, efficacy and acceptability of SARS-CoV-2 vaccines in patients with cancer Roy Chebel, Chris Labaki, Maria Farhat, Joseph Kattan
122 [GO] 2021―Jun―22 The COVID-19 pandemic: an increased risk of rheumatoid arthritis Archana Tripathy, Nitish Swain, Bhawna Gupta
123 [GO] 2021―Jun―22 V483A: an emerging mutation hotspot of SARS-CoV-2 Omar Ashwaq, Pratibha Manickavasagam, SK Manirul Haque
124 [GO] 2021―Jun―22 Vertical transmission potential of SARS-CoV-2 from infected mother to twin neonates Liangyu Peng, Suliman Khan, Ashaq Ali, Saeed Ahmed, Liaqat Ali, Guang Han, Yang Jing
125 [GO] 2021―Jun―01 Druggability of cavity pockets within SARS-CoV-2 spike glycoprotein and pharmacophore-based drug discovery Alireza Mohebbi, Fatemeh Sana Askari, Ali Salehnia Sammak, Mohsen Ebrahimi, Zahra Najafimemar
126 [GO] 2021―May―24 Tocilizumab in the treatment of coronavirus disease 2019 pneumonia: real-world data from a case series Ran Cui, Ying Zhu, Yulan Wang, Xiao-Hua Chen, Qiang Li, Sheng-Ming Dai, Qiang Tong
127 [GO] 2021―May―19 Natural selection on synonymous mutations in SARS-CoV-2 and the impact on estimating divergence time Yuanyuan Yu, Yan Li, Yu Dong, Xuekun Wang, Chunxiao Li, Wenqing Jiang
128 [GO] 2021―May―19 SARS-CoV-2 likely targets cellular PDZ proteins: a common tactic of pathogenic viruses Andrew P Rice, Jason T Kimata
129 [GO] 2021―May―12 Predictive values of biochemical markers as early indicators for severe COVID-19 cases in admission Emin Gemcioglu, Mehmet Davutoglu, Ramis Catalbas, Berkan Karabuga, Enes Kaptan, Adalet Aypak, et al. (+8)
130 [GO] 2021―Apr―26 An analysis of inhibition of the severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase by zinc ion: an in silico approach Sina Zoghi, Hossein Jafari Khamirani, Seyed Alireza Dastgheib, Mehdi Dianatpour, Alireza Ghaffarieh
131 [GO] 2021―Apr―22 HIV and COVID-19 pandemic collision: turning challenges into opportunity Stefano Rusconi, Laura Pezzati, Tiziana Formenti, Andrea Giacomelli
132 [GO] 2021―Apr―21 Investigation of the relationship between inherited thrombophilia and novel coronavirus pneumonia Aslihan Kiraz, Seda Guzeldag, Esma Eren, Musa Goksu, Arslan Bayram
133 [GO] 2021―Apr―14 The initial infectious dose of SARS-CoV-2 and the severity of the disease: possible impact on the incubation period Hamid Tayebi Khosroshahi, Alireza Mardomi
134 [GO] 2021―Apr―07 Abnormal myocardial enzymes are important indicators of poor prognosis in COVID-19 patients Jingping Cheng, Wanxin Liu, Siyang Chen, Xiafen Hu, Xiaochen Xiang, Zhongliang Cheng, et al. (+5)
135 [GO] 2021―Apr―06 Xerostomia (dry mouth) in patients with COVID-19: a case series Yaser Fathi, Elaheh Ghasemzadeh Hoseini, Fatemeh Atoof, Reza Mottaghi
136 [GO] 2021―Mar―25 Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach Abhigyan Choudhury, Nabarun C Das, Ritwik Patra, Manojit Bhattacharya, Pratik Ghosh, Bidhan C Patra, Suprabhat Mukherjee
137 [GO] 2021―Mar―24 The role of miRNAs in COVID-19 disease Mona Fani, Milad Zandi, Saeedeh Ebrahimi, Saber Soltani, Samaneh Abbasi
138 [GO] 2021―Mar―09 Erythema multiform-like lesions in a patient infected with SARS-CoV-2: a case report Yaser Fathi, Elaheh Ghasemzadeh Hoseini, Reza Mottaghi
139 [GO] 2021―Mar―08 Comparative sequence analysis of SARS-CoV-2 suggests its high transmissibility and pathogenicity Kartika Padhan, Mohammad K Parvez, Mohammed S Al-Dosari
140 [GO] 2021―Mar―02 Computational guided approach for drug repurposing against SARS-CoV-2 Jigisha Anand, Tanmay Ghildiyal, Aakanksha Madhwal, Rishabh Bhatt, Devvret Verma, Nishant Rai
141 [GO] 2021―Feb―24 Epidemiologic features and clinical course of COVID-19: a retrospective analysis of 19 patients in Germany Sara Elgamasy, Eman Elsayed Sakr, Mohamed Gomaa Kamel, Sherief Ghozy, Ghadeer Gamal Elsayed, Mostafa Mahmoud Fahmy, et al. (+3)
142 [GO] 2021―Feb―22 Scouting the receptor-binding domain of SARS coronavirus 2: a comprehensive immunoinformatics inquisition Zaira Rehman, Ammad Fahim, Muhammad Faraz Bhatti
143 [GO] 2021―Feb―09 The long-quarantined case of COVID-19 with prolonged viral shedding and intermittent fever for more than 70 days Eijiro Yamada, Emi Ishida, Yasuyo Nakajima, Kazuhiko Horiguchi, Shunichi Matsumoto, Shuichi Okada, et al. (+2)
144 [GO] 2021―Feb―04 What is the intermediate host species of SARS-CoV-2? Thomas Friend, Justin Stebbing
145 [GO] 2021―Feb―03 SARS-CoV-2 direct real-time polymerase chain reaction testing in laboratories with shortage challenges Taghreed Alaifan, Asmaa Altamimi, Dalia Obeid, Turki Alshehri, Shaihana Almatrrouk, Ahmed Albarrag
146 [GO] 2021―Jan―28 Asymptomatic carriers of coronavirus disease 2019 among healthcare workers in Isfahan, Iran Hamed Fakhim, Elahe Nasri, Shima Aboutalebian, Sahar Gholipour, Mahnaz Nikaeen, Afsane Vaezi, et al. (+8)
147 [GO] 2021―Jan―26 Severe acute respiratory syndrome coronavirus 2 viral load in respiratory and feces specimens of children with coronavirus disease 2019 Xiang Ma, Liang Su, Lu Cheng, Zhaohua Zhang, Jing Sun, Miao Liu, et al. (+6)
148 [GO] 2021―Jan―25 Clinical characteristics of outpatients and inpatients with COVID-19 in Bushehr: a report from the south of Iran Mohsen Keshavarz, Ahmad Tavakoli, Sareh Zanganeh, Mohammad Javad Mousavi, Katayoun Vahdat, Mehdi Mahmudpour, et al. (+3)
149 [GO] 2021―Jan―13 Mechanisms of infection by SARS-CoV-2, inflammation and potential links with the microbiome María Magdalena Aguirre García, Javier Mancilla-Galindo, Mercedes Paredes-Paredes, Álvaro Zamudio Tiburcio, Nydia Ávila-Vanzzini
150 [GO] 2021―Jan―07 A new perspective of the chemistry and kinetics of inactivation of COVID -19 coronavirus aerosols Michael L Hitchman
151 [GO] 2020―Dec―24 Relationship between IL-6 and COVID-19: to be considered during treatment Hafize Seda Vatansever, Eda Becer
152 [GO] 2020―Dec―16 Pandemic response management framework based on efficiency of COVID-19 control and treatment Mustapha D Ibrahim, Fatima AS Binofai, Reem MM Alshamsi
153 [GO] 2020―Dec―15 Can natural detergent properties of bile acids be used beneficially in tackling coronavirus disease-19? Yashwant Kumar, Reena Yadav, Alka Bhatia
154 [GO] 2020―Nov―30 Phylogenomics and phylodynamics of SARS-CoV-2 genomes retrieved from India Sameera Farah, Ashwin Atkulwar, Manas Ranjan Praharaj, Raja Khan, Ravikumar Gandham, Mumtaz Baig
155 [GO] 2020―Nov―26 The role of artificial intelligence in tackling COVID-19 Neelima Arora, Amit K Banerjee, Mangamoori L Narasu
156 [GO] 2020―Nov―26 Phylogenetic and whole genome analysis of first seven SARS-CoV-2 isolates in Bangladesh Nadim Sharif, Shuvra K Dey
157 [GO] 2020―Nov―04 LIF and the lung’s stem cell niche: is failure to use LIF to protect against COVID-19 a grave omission in managing the pandemic? Su M Metcalfe
158 [GO] 2020―Oct―28 A multiple-center clinical evaluation of a new real-time reverse transcriptase PCR diagnostic kit for SARS-CoV-2 Jing-Jing Guo, Yan-Hua Yu, Xue-Ying Ma, Ya-Nan Liu, Qian Fang, Pei Qu, et al. (+3)
159 [GO] 2020―Oct―27 Perversely expressed long noncoding RNAs can alter host response and viral proliferation in SARS-CoV-2 infection Rafeed Rahman Turjya, Md. Abdullah-Al-Kamran Khan, Abul Bashar Mir Md. Khademul Islam
160 [GO] 2020―Oct―22 Clinical characteristics and outcomes of discharged COVID-19 patients with reoccurrence of SARS-CoV-2 RNA Jing Wu, Xiao-ying Xia, He-lei Liu, Hong Xia, Wen-xiang Huang, Bei Jia, Feng-ying Peng
161 [GO] 2020―Oct―14 A comprehensive review about SARS-CoV-2 SK Manirul Haque, Omar Ashwaq, Abdulla Sarief, Abdul Kalam Azad John Mohamed
162 [GO] 2020―Oct―13 Implications of current and future approaches to coronavirus disease 2019 testing Rasheid Smith, Sean M Geary, Aliasger K Salem
163 [GO] 2020―Oct―08 The potential of lactoferrin, ovotransferrin and lysozyme as antiviral and immune-modulating agents in COVID-19 Jaclyn Kelly Mann, Thumbi Ndung'u
164 [GO] 2020―Oct―08 In silico analysis of protein/peptide-based inhalers against SARS-CoV-2 Saad Salman, Fahad Hassan Shah, Maham Chaudhry, Muniba Tariq, Muhammad Yasir Akbar, Muhammad Adnan
165 [GO] 2020―Aug―26 Investigation of compatibility of severe acute respiratory syndrome coronavirus 2 reverse transcriptase-PCR kits containing different gene targets during coronavirus disease 2019 pandemic Figen Sarıgül, Osman Doluca, Sıla Akhan, Murat Sayan
166 [GO] 2020―Aug―26 Genetic and pathogenic characterization of SARS-CoV-2: a review Afsane Bahrami, Gordon A Ferns
167 [GO] 2020―Aug―18 A flow virometry process proposed for detection of SARS-CoV-2 and large-scale screening of COVID-19 cases Niraja Soni, Puja Pai, Gurumurthy Raja Krishna Kumar, Venkatesh Prasad, Santanu Dasgupta, Bhaskar Bhadra
168 [GO] 2020―Aug―17 Susceptibility of the Iranian population to severe acute respiratory syndrome coronavirus 2 infection based on variants of angiotensin I converting enzyme 2 Alireza Mohebbi, Fatemeh Sana Askari, Mohsen Ebrahimi, Mana Zakeri, Mohammad Yasaghi, Hanieh Bagheri, Naeme Javid
169 [GO] 2020―Aug―12 Thoughts on detecting tissue distribution of potential COVID-19 receptors Hongtao Tang, Xiaosheng Lu, Shuyan Qie, Jianing Xi
170 [GO] 2020―Jul―29 In silico identification of conserved cis-acting RNA elements in the SARS-CoV-2 genome Bader Y Alhatlani
171 [GO] 2020―Jul―27 COVID-19: studying the global pandemic - foreword Stefano Rusconi, Frederick G Hayden
172 [GO] 2020―Jul―27 Therapeutic and vaccine strategies against SARS-CoV-2: past, present and future Mubasher Rehman, Isfahan Tauseef, Bibi Aalia, Sajid Hussain Shah, Muhammad Junaid, Kashif Syed Haleem
173 [GO] 2020―Jun―26 COVID-19 in homeless populations: unique challenges and opportunities Brian Conway, David Truong, Kelli Wuerth
174 [GO] 2020―Jun―12 COVID-19 and coronaviral hepatitis: evidence of collateral damage Mohammad K Parvez
175 [GO] 2020―Jun―12 Transmission and clinical characteristics of asymptomatic patients with SARS-CoV-2 infection Jie Tan, Shousheng Liu, Likun Zhuang, Lizhen Chen, Mengzhen Dong, Jie Zhang, Yongning Xin
176 [GO] 2020―May―29 A suspected case of COVID-19 turned into a confirmed case: a case report from Iran Di Yang, Kai Wei, Xuesong Gao, Yijin Zhang, Ping Gao, Hongjie Li, et al. (+5)
177 [GO] 2020―May―26 Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection: let the virus be its own demise John Nemunaitis, Laura Stanbery, Neil Senzer
178 [GO] 2020―May―20 Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections Mona Fani, Ali Teimoori, Shokouh Ghafari
179 [GO] 2020―May―12 Prediction and analysis of key protein structures of 2019-nCoV Qihao Li, Wen Peng, Yu Ou
180 [GO] 2020―Apr―24 The divergence between SARS-CoV-2 and RaTG13 might be overestimated due to the extensive RNA modification Yue Li, Xinai Yang, Na Wang, Haiyan Wang, Bin Yin, Xiaoping Yang, Wenqing Jiang
181 [GO] 2020―Apr―17 Pros and cons of the application of evolutionary theories to the evolution of SARS-CoV-2 Yue Li, Xinai Yang, Na Wang, Haiyan Wang, Bin Yin, Xiaoping Yang, Wenqing Jiang
 [1] 

181 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec